Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Heath

Showing results (411-420 of 437) with videos related to

Pageof 44
Sort By:
Genetics, Selection, Evolution : GSE|December 17, 2004
Physiological effects of major genes affecting ovulation rate in sheepKenneth P McNatty, Susan M Galloway, Theresa Wilson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 13, 1999
Novel mutations in the 1alpha-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophagesS J Smith, A K Rucka, J L Berry, et al.
The Journal of Allergy and Clinical Immunology. Global|March 27, 2026
A novel ambient air sampler for detection of allergens and endotoxinMaria A Oliver, Rhys T Meredith, Max D Bermingham, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 3: synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanesMukund M Mehrotra, Julie A Heath, Jack W Rose, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2014
Aberrant GDF9 expression and activation are associated with common human ovarian disordersCourtney M Simpson, David M Robertson, Sara L Al-Musawi, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2015
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's diseaseB G Feagan, W J Sandborn, G D'Haens, et al.
Annals of Neurology|April 1, 2009
Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strainJean-Philippe Brandel, Craig A Heath, Mark W Head, et al.
Biology of Reproduction|November 22, 2002
Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheepJennifer L Juengel, Norma L Hudson, Derek A Heath, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 22, 2006
Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UKC A Heath, R A Barker, T F G Esmonde, et al.
Journal of Medicinal Chemistry|April 2, 2004
Discovery of novel 2,8-diazaspiro[4.5]decanes as orally active glycoprotein IIb-IIIa antagonistsMukund M Mehrotra, Julie A Heath, Mark S Smyth, et al.
Pageof 44

Showing results (411-420 of 437) with videos related to

Sort By:
Pageof 44
Genetics, Selection, Evolution : GSE|December 17, 2004
Physiological effects of major genes affecting ovulation rate in sheepKenneth P McNatty, Susan M Galloway, Theresa Wilson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 13, 1999
Novel mutations in the 1alpha-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophagesS J Smith, A K Rucka, J L Berry, et al.
The Journal of Allergy and Clinical Immunology. Global|March 27, 2026
A novel ambient air sampler for detection of allergens and endotoxinMaria A Oliver, Rhys T Meredith, Max D Bermingham, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 3: synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanesMukund M Mehrotra, Julie A Heath, Jack W Rose, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2014
Aberrant GDF9 expression and activation are associated with common human ovarian disordersCourtney M Simpson, David M Robertson, Sara L Al-Musawi, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2015
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's diseaseB G Feagan, W J Sandborn, G D'Haens, et al.
Annals of Neurology|April 1, 2009
Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strainJean-Philippe Brandel, Craig A Heath, Mark W Head, et al.
Biology of Reproduction|November 22, 2002
Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheepJennifer L Juengel, Norma L Hudson, Derek A Heath, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 22, 2006
Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UKC A Heath, R A Barker, T F G Esmonde, et al.
Journal of Medicinal Chemistry|April 2, 2004
Discovery of novel 2,8-diazaspiro[4.5]decanes as orally active glycoprotein IIb-IIIa antagonistsMukund M Mehrotra, Julie A Heath, Mark S Smyth, et al.
Pageof 44